Evidence map›Paper›PMID 38744291›Full record

ArticleImmunity2024

Tuft cell-derived acetylcholine promotes epithelial chloride secretion and intestinal helminth clearance.

Tyler E Billipp, Connie Fung, Lily M Webeck, Derek B Sargent, Matthew B Gologorsky, Zuojia Chen, Margaret M McDaniel, Darshan N Kasal, John W McGinty, Kaitlyn A Barrow and 8 more

Abstract read
In one paragraph

Article in Immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Tyler E BillippDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
Connie FungDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Lily M WebeckDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
Derek B SargentDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
Matthew B GologorskyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Zuojia ChenExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Margaret M McDanielDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
Darshan N KasalDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
John W McGintyDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA.
Kaitlyn A BarrowCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, WA, USA.
Lucille M RichCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, WA, USA.
Alessio BarilliAptuit, an Evotec Company, Verona, Italy.
Mark SabatTakeda Pharmaceuticals, San Diego, CA, USA.
Jason S DebleyCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Chuan WuExperimental Immunology Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Richard MyersTakeda Pharmaceuticals, San Diego, CA, USA.
Michael R HowittDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jakob von MoltkeDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: jmoltke@uw.edu.

Funding

The Bioinformatics and Data Management Core (BDMC)U19AI175089 · NIAID · UNIVERSITY OF WASHINGTON · PI JASON S DEBLEY, Teal S Hallstrand · 2023 to 2026
$7.8M
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodelingR01AI163160 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JASON S DEBLEY · 2022 to 2026
$4.3M
Tuft cell effector functions in the small intestineR01AI145848 · NIAID · UNIVERSITY OF WASHINGTON · PI VON MOLTKE, JAKOB H. · 2020 to 2024
$2.8M
Regulation of the tuft-ILC2 circuit in the small intestineR01AI167923 · NIAID · UNIVERSITY OF WASHINGTON · PI Jakob H. von Moltke · 2022 to 2026
$2.8M
Sensing of helminths by tuft cellsDP2AI136596 · NIAID · UNIVERSITY OF WASHINGTON · PI VON MOLTKE, JAKOB H. · 2017 to 2017
$2.6M
Impact of symbiotic protists on intestinal T cell homeostasis and inflammation.R01DK128292 · NIDDK · STANFORD UNIVERSITY · PI HOWITT, MICHAEL R · 2021 to 2025
$2.3M
Immune-neuron crosstalk regulates intestinal homeostasisZIABC012034 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WU, CHUAN · 2021 to 2025
$2.0M
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic ChildrenR01HL128361 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2016 to 2018
$1.4M
Tuft Cell Effector Functions in the IntestineR37AI145848 · NIAID · UNIVERSITY OF WASHINGTON · PI Jakob H. von Moltke · 2025 to 2026
$1.4M
Impact of Heterogeneous Airway Epithelial ACE2 Expression and Interferon Responses on SARS-CoV2 Infectivity and ReplicationK24AI150991 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI DEBLEY, JASON S · 2020 to 2024
$1.2M
Tuft cell regulation of Peyers patch composition and organizationR21AI171222 · NIAID · STANFORD UNIVERSITY · PI HOWITT, MICHAEL R · 2022 to 2023
$438k
Acquisition of BD FACSymphony A3 Lite Flow CytometerS10OD024979 · OD · UNIVERSITY OF WASHINGTON · PI BLACK, MICHELE C · 2020 to 2020
$344k
NHLBI NIH HHS R01 HL128361NIAID NIH HHS DP2 AI136596NIAID NIH HHS K24 AI150991NIAID NIH HHS R01 AI145848NIAID NIH HHS R01 AI163160NIAID NIH HHS R01 AI167923NIAID NIH HHS R21 AI171222NIAID NIH HHS R37 AI145848NIAID NIH HHS U19 AI175089NIDDK NIH HHS R01 DK128292NIH HHS S10 OD024979
6 · The paper itself

Abstract

Epithelial cells secrete chloride to regulate water release at mucosal barriers, supporting both homeostatic hydration and the "weep" response that is critical for type 2 immune defense against parasitic worms (helminths). Epithelial tuft cells in the small intestine sense helminths and release cytokines and lipids to activate type 2 immune cells, but whether they regulate epithelial secretion is unknown. Here, we found that tuft cell activation rapidly induced epithelial chloride secretion in the small intestine. This response required tuft cell sensory functions and tuft cell-derived acetylcholine (ACh), which acted directly on neighboring epithelial cells to stimulate chloride secretion, independent of neurons. Maximal tuft cell-induced chloride secretion coincided with immune restriction of helminths, and clearance was delayed in mice lacking tuft cell-derived ACh, despite normal type 2 inflammation. Thus, we have uncovered an epithelium-intrinsic response unit that uses ACh to couple tuft cell sensing to the secretory defenses of neighboring epithelial cells.

Indexed as

AcetylcholineChloridesEpithelial CellsIntestinal MucosaAnimalsIntestine, SmallMiceMice, Inbred C57BLMice, KnockoutTuft CellsAcetylcholineChloridesacetylcholinechloride secretionhelminth infectionintestinetuft celltype 2 immunity

Identifiers

PMID38744291
PMCPMC11168877

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.